Ornicon Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.80 M
About Ornicon Pharma
Ornicon Pharma Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2010 and has a history of 14 years and 11 months. Its registered office is in Dakshina Kannada, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹1.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Manoj Shastry and Parvathi Shastry serve as directors at the Company.
Company Details
-
Location
Dakshina Kannada, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909KA2010PTC052841
-
Company No.
052841
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Mar 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Ornicon Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Shastry
|
Director | 07-Jan-2019 | Current |
|
Parvathi Shastry
|
Director | 08-Feb-2019 | Current |
Financial Performance of Ornicon Pharma.
Ornicon Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ornicon Pharma?
In 2017, Ornicon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lore & Care India Private LimitedManoj Shastry and Parvathi Shastry are mutual person
-
Saharsham Lands And Infrastructures Private Limited
Manoj Shastry and Parvathi Shastry are mutual person
Charges (Loans)
₹0
₹1.80 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Sep 2017 | Canara Bank | ₹1.50 M | Satisfied |
| 17 Mar 2015 | Canara Bank | ₹0.30 M | Satisfied |
How Many Employees Work at Ornicon Pharma?
Unlock and access historical data on people associated with Ornicon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ornicon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ornicon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
